These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8372404)

  • 1. Estimation of antagonist Kb from inhibition curves in functional experiments: alternatives to the Cheng-Prusoff equation.
    Lazareno S; Birdsall NJ
    Trends Pharmacol Sci; 1993 Jun; 14(6):237-9. PubMed ID: 8372404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng-Prusoff equations.
    Lazareno S; Birdsall NJ
    Br J Pharmacol; 1993 Aug; 109(4):1110-9. PubMed ID: 8401922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The power issue: determination of KB or Ki from IC50. A closer look at the Cheng-Prusoff equation, the Schild plot and related power equations.
    Cheng HC
    J Pharmacol Toxicol Methods; 2001; 46(2):61-71. PubMed ID: 12481843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of cooperativity on the determination of dissociation constants: examination of the Cheng-Prusoff equation, the Scatchard analysis, the Schild analysis and related power equations.
    Cheng HC
    Pharmacol Res; 2004 Jul; 50(1):21-40. PubMed ID: 15082026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of competitive antagonist affinity by the Schild method and from functional inhibition curves using a novel form of the Gaddum equation.
    Ezechiáš M; Cajthaml T
    Toxicology; 2019 May; 420():21-28. PubMed ID: 30935971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cheng-Prusoff relationship: something lost in the translation.
    Craig DA
    Trends Pharmacol Sci; 1993 Mar; 14(3):89-91. PubMed ID: 8488569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further concerns over Cheng-Prusoff analysis.
    Leff P; Dougall IG
    Trends Pharmacol Sci; 1993 Apr; 14(4):110-2. PubMed ID: 8516953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An alternative method to evaluate the nature of an antagonist and its potency: a theoretical approach.
    Calderone V
    J Pharmacol Toxicol Methods; 1998 Apr; 39(3):129-35. PubMed ID: 9741386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Problems associated with the application of the Cheng-Prusoff relationship to estimate atropine affinity constants using functional tissue responses.
    Eglen RM; Whiting RL
    Life Sci; 1989; 44(1):81-94. PubMed ID: 2913438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Schild regression in the process of receptor classification.
    Kenakin TP
    Can J Physiol Pharmacol; 1982 Mar; 60(3):249-65. PubMed ID: 7042056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of antagonist dose-response curves for estimation of pA2-values by Schild-plot analysis and detection of allosteric interactions.
    Pöch G; Brunner F; Kühberger E
    Br J Pharmacol; 1992 Jul; 106(3):710-6. PubMed ID: 1504755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental and theoretical comparisons between the classical Schild analysis and a new alternative method to evaluate the pA2 of competitive antagonists.
    Calderone V; Baragatti B; Breschi MC; Martinotti E
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):477-87. PubMed ID: 10598787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation.
    Black JW; Leff P; Shankley NP; Wood J
    Br J Pharmacol; 1985 Feb; 84(2):561-71. PubMed ID: 3978322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing receptor affinity for inverse agonists: Schild and Cheng-Prusoff methods revisited.
    Giraldo J; Serra J; Roche D; Rovira X
    Curr Drug Targets; 2007 Jan; 8(1):197-202. PubMed ID: 17266542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonist inhibition curves and the measurement of dissociation constants.
    Barlow RB; Bond SM; Bream E; Macfarlane L; McQueen DS
    Br J Pharmacol; 1997 Jan; 120(1):13-8. PubMed ID: 9117087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Apparent Noncompetitive Responses to Competitive H(1)-Histamine Receptor Antagonists in Fluorescent Imaging Plate Reader-Based Calcium Assays.
    Miller TR; Witte DG; Ireland LM; Kang CH; Roch JM; Masters JN; Esbenshade TA; Hancock AA
    J Biomol Screen; 1999; 4(5):249-258. PubMed ID: 10838445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of agonist affinity, using the slope of the concentration-effect curve: comment on the method of Calderone and Martinotti.
    Van der Graaf PH
    J Pharmacol Toxicol Methods; 1998 Nov; 40(4):241-3. PubMed ID: 10465160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An exact correction to the "Cheng-Prusoff" correction.
    Munson PJ; Rodbard D
    J Recept Res; 1988; 8(1-4):533-46. PubMed ID: 3385692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the operational model of agonism to establish conditions when functional antagonism may be used to estimate agonist dissociation constants.
    Leff P; Martin GR; Morse JM
    Br J Pharmacol; 1985 Jul; 85(3):655-63. PubMed ID: 4027483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developments of computer-based estimation of pA2 values and associated analysis.
    Stone M; Angus JA
    J Pharmacol Exp Ther; 1978 Dec; 207(3):705-18. PubMed ID: 731426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.